A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the disease from coming back. The trial was tiny, just 16 patients, but it’s ...
Friends, family, and the Cathedral Prep community gathered at the Hagerty Family Events Center to honor the legendary Pat ...
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...
In the seriously great news department, pancreatic cancer is expected to pass colorectal cancer as the second biggest cause ...
The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...
ZME Science on MSN3d
A Simple Blood Test Called PAC-MANN Could Detect Pancreatic Cancer Early and Save Thousands of LivesA new study from researchers at the Oregon Health and Science University (OHSU) proposes a test called PAC-MANN, which could ...
The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...
Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback